Francie Barron, PhD

I help biotech companies turn scientific innovation into commercial reality. With a PhD in cell biology and over a decade of business development experience, I bridge the gap between R&D, regulatory strategy, and commercial execution. I’ve closed $4.6M in partnership contracts across life science tools and diagnostics, working with organizations from startups to Fortune 100 […]

Stephanie Astrow, PhD, MBA

Healthcare executive and scientist with 25+ years of leadership in biotechnology, focused on turning scientific innovation into commercial and clinical impact. Proven track record advancing first-in-class therapies and diagnostics, securing FDA clearances, and driving growth across public and private companies—including generating $10M+ in oncology revenue, expanding diagnostic portfolios, and managing a $30M P&L. Currently Chief […]

Allyson J. Ocean, M.D.

I am a Board Director at Novocure and a physician-scientist focused on oncology innovation, clinical development strategy, and translational medicine. As Professor of Clinical Medicine at Weill Cornell Medicine, I bring over two decades of leadership in precision oncology and clinical research. I help life sciences organizations translate scientific breakthroughs into clinically meaningful therapies by […]